Active Government Funding Opportunities

Support early-stage researchers investigating Multiple Sclerosis through independent, mentor-guided projects. This award develops the next generation of MS researchers by funding novel research questions and advancing scientific careers in neuroimmunology.

DoD seeks interventional lupus research with near-term health impact, including clinical trials and health system innovations. Teams must include patient advocates and provide preliminary data demonstrating feasibility and potential quality-of-life improvements.

Support rigorous, investigator-initiated research projects advancing Multiple Sclerosis understanding and patient outcomes. Funding available for laboratory, clinical, and population-based studies with preliminary data, including dedicated tracks for early-career investigators.

The Army seeks clinical trial research to advance vision capabilities and treatments. This opportunity supports innovative medical studies addressing soldier visual performance and eye health.

Army seeks investigator-initiated research proposals addressing vision science and ocular performance challenges. Support ranges from basic science through applied research to advance soldier visual capabilities and medical treatments.

TechConnect seeks innovative technologies to identify, secure, and communicate hazardous energy risks in workplaces. Solutions should advance lockout/tagout capabilities to reduce worker injuries and fatalities across industries.

DOJ seeks rigorous research on how drug trafficking and firearms intersect to fuel violence. Projects should develop evidence-based tools and strategies for law enforcement to disrupt drug markets and prosecute related crimes.

Establish a breast cancer research consortium by bringing together investigators and patient advocates to develop preliminary research and framework. This development award prepares teams for a future full consortium competition addressing critical gaps in breast cancer science.

This DoD award funds multidisciplinary, multi-institutional consortia addressing transformative breast cancer research challenges. Led by up to five PIs and consumer advocates, projects must tackle major problems requiring collaborative breakthroughs that single investigators cannot achieve.

This pilot award funds innovative ovarian cancer research that challenges current thinking and explores novel concepts to drive breakthrough discoveries. Projects must demonstrate exceptional scientific merit and innovative approaches to advance the field.

Mission Engineering Automation Testbed (MEAT) seeks prototypes for automated mission engineering and Live/Virtual/Constructive integration with secure interoperable ecosystem.

LYNX Software Technologies COTS software acquisition for Combat Rescue Helicopter development and sustainment operations.

Support high-impact investigator-initiated research addressing ovarian cancer through basic laboratory to translational studies. Projects must demonstrate strong scientific rationale with preliminary data and potential to advance patient care.

Support early-career ovarian cancer researchers through an intensive virtual academy offering mentoring, networking, and collaboration. The program develops productive scientists while advancing innovative ovarian cancer research in a structured peer-learning environment.

This DoD program funds breakthrough breast cancer research addressing major scientific challenges with potential for clinical impact. Researchers can pursue Level 1 or 2 funding, partnering with co-investigators and population science studies to accelerate discoveries from bench to bedside.

DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.

Support early-career clinical trialists developing new ovarian cancer treatments through intensive mentoring, networking, and conducting translational research and early-phase clinical trials.

This award extends ongoing breast cancer clinical studies by completing data collection, follow-up, and analysis to maximize patient participation impact. It addresses knowledge gaps from early trial termination or incomplete data gathering.

This award funds clinical trials for new ovarian cancer treatments, from early proof-of-concept studies through large-scale efficacy trials. It supports evaluation of drugs, biologics, devices, and emerging technologies to improve patient outcomes.

Supports early-career breast cancer researchers demonstrating exceptional creative potential and innovative thinking. The award recognizes talented scientists with strong collaboration skills and leadership promise to advance meaningful solutions in breast cancer research.

DoD seeks breakthrough breast cancer research with high clinical potential, supporting projects from preclinical through early clinical stages. Applications must address priority research challenges and include consumer advocates as core team members.

Research and evaluate justice system responses to human trafficking and technology-enabled trafficking investigations, with focus on improving prosecutions, victim services, and law enforcement capabilities at the Southern Border.

Develop ALS therapeutics from preclinical validation through FDA IND-enabling studies. This award accelerates drug candidates toward clinical testing while requiring parallel development of mechanism-specific biomarkers for improved patient selection and trial design.

This DoD funding supports high-risk, hypothesis-driven research to discover new ALS drugs and therapies. Applications emphasizing novel approaches can succeed without preliminary data, enabling bold therapeutic innovation.

Develop and validate clinical biomarkers and outcome measures to improve ALS clinical trials, including digital health tools like wearables and AI-enabled monitoring. Projects should incorporate patient community input and may target specific ALS subtypes or therapeutic classes.